pneumonia
respiratori
infect
alveolar
space
vari
mild
outpati
ill
sever
ill
necessit
hospit
intens
care
sixth
lead
caus
death
us
number
one
caus
death
infecti
diseas
infect
occur
patient
live
commun
term
communityacquir
pneumonia
cap
call
nosocomi
pneumonia
aris
patient
alreadi
hospit
present
distinct
communityacquir
nosocomi
infect
less
clear
commun
includ
complex
patient
recent
hospit
nurs
home
chronic
diseas
commonli
manag
facil
dialysi
center
nurs
home
latter
group
develop
pneumonia
term
healthcar
associ
pneumonia
hcap
ill
share
clinic
featur
cap
etiolog
pathogen
may
overlap
seen
tradit
nosocomi
pneumonia
thu
relationship
bacteriolog
site
origin
infect
reflect
sever
factor
includ
type
patient
develop
ill
host
defens
relat
predisposit
infect
specif
pathogen
environment
exposur
certain
organ
discuss
focus
pneumonia
aris
hospit
immunecompet
individu
exclud
discuss
patient
human
immunodefici
viru
hiv
infect
tradit
immun
suppress
cancer
chemotherapi
immun
suppress
medic
million
peopl
diagnos
cap
us
major
million
treat
hospit
although
major
case
cap
manag
outpati
set
greater
part
cost
treatment
focus
hospit
patient
admit
hospit
commonli
tend
older
high
frequenc
comorbid
ill
us
popul
elderli
patient
increas
age
make
onethird
cap
patient
group
account
half
cost
frequent
need
elderli
cap
patient
hospit
report
mortal
cap
vari
popul
evalu
rang
less
among
outpati
among
hospit
cap
patient
rise
among
admit
intens
care
unit
icu
studi
focus
inhospit
mortal
cap
one
recent
evalu
cap
patient
age
found
shortterm
risk
inhospit
mortal
ill
death
rate
mortal
rate
year
emphas
mani
patient
cap
marker
underli
seriou
comorbid
predictor
poor
outcom
even
hospit
discharg
varieti
reason
find
add
emphasi
pneumonia
prevent
especi
use
avail
vaccin
complex
cap
manag
also
increas
etiolog
pathogen
chang
histor
cap
regard
bacteri
ill
caus
one
pathogen
streptococcu
pneumonia
today
number
etiolog
pathogen
mushroom
includ
bacteria
also
virus
influenza
sever
acut
respiratori
syndrom
sar
fungi
number
recent
identifi
organ
legionella
chlamydophila
pneumonia
number
pathogen
expand
abil
treat
challeng
rise
frequenc
resist
among
bacteria
wide
rang
commonli
use
often
overus
antimicrobi
agent
pneumonia
infect
gasexchang
unit
lung
commonli
caus
bacteria
occasion
caus
virus
fungi
parasit
infecti
agent
immunocompet
individu
character
brisk
fill
alveolar
space
inflammatori
cell
fluid
alveolar
infect
involv
entir
anatom
lobe
lung
term
lobar
pneumonia
multilobar
ill
present
instanc
alveolar
process
occur
distribut
patchi
adjac
bronchi
without
fill
entir
lobe
term
bronchopneumonia
pneumonia
occur
patient
host
defens
overwhelm
infecti
pathogen
happen
patient
inadequ
immun
respons
often
result
underli
comorbid
ill
congest
heart
failur
diabet
renal
failur
chronic
obstruct
lung
diseas
malnutrit
anatom
abnorm
endobronchi
obstruct
bronchiectasi
result
acut
illnessassoci
immun
dysfunct
occur
sepsi
acut
lung
injuri
therapyinduc
dysfunct
immun
system
corticosteroid
endotrach
intub
pneumonia
also
occur
patient
adequ
immun
system
host
defens
system
overwhelm
larg
inoculum
microorgan
occur
patient
massiv
aspir
gastric
content
patient
outsid
hospit
normal
immun
system
overcom
particularli
virul
organ
patient
preexist
immun
certain
bacteria
virus
patient
inabl
form
adequ
acut
immun
respons
bacteria
enter
lung
via
sever
rout
aspir
previous
colon
oropharynx
common
way
organ
lead
pneumonia
although
pneumonia
result
microaspir
patient
also
aspir
larg
volum
bacteria
impair
neurolog
protect
upper
airway
stroke
seizur
intestin
ill
predispos
vomit
rout
entri
includ
inhal
appli
primarili
virus
legionella
pneumophila
mycobacterium
tuberculosi
hematogen
dissemin
extrapulmonari
site
infect
rightsid
endocard
direct
extens
contigu
site
infect
liver
abscess
keep
concept
mind
easi
understand
previous
healthi
individu
develop
infect
virul
pathogen
virus
l
pneumophila
mycoplasma
pneumonia
c
pneumonia
pneumonia
hand
chronic
ill
patient
infect
organ
well
organ
commonli
colon
patient
caus
infect
immun
respons
inadequ
organ
includ
enter
gramneg
bacteria
escherichia
coli
klebsiella
pneumonia
pseudomona
aeruginosa
acinetobact
spp
fungi
recent
studi
evalu
normal
lung
immun
respons
infect
shown
gener
compartment
thu
patient
unilater
pneumonia
inflammatori
respons
limit
site
infect
spill
uninvolv
lung
system
circul
patient
local
pneumonia
tumor
necrosi
factor
tnf
interleukin
level
increas
pneumon
lung
gener
increas
uninvolv
lung
serum
patient
sever
pneumonia
immun
respons
character
spillov
immun
respons
system
circul
reflect
increas
serum
level
tnf
remain
uncertain
local
occur
individu
patient
develop
diffus
lung
injuri
acut
respiratori
distress
sydrom
ard
system
sepsi
consequ
pneumonia
recent
studi
suggest
genet
polymorph
may
explain
differ
patient
certain
inherit
pattern
immun
respons
prone
other
sever
form
pneumonia
even
mortal
ill
exampl
certain
genet
polymorph
associ
greater
risk
death
sepsi
cap
specif
polymorph
increas
sepsi
mortal
mortal
cap
addit
cap
sever
increas
genet
chang
locu
often
present
along
chang
locu
anoth
genet
chang
associ
increas
risk
septic
shock
cap
modif
heat
shock
protein
current
awar
larg
number
gene
affect
sever
outcom
cap
much
must
learn
put
find
true
clinic
context
even
extens
diagnost
test
etiolog
agent
defin
half
patient
cap
point
limit
valu
diagnost
test
possibl
know
organ
caus
cap
exampl
past
three
decad
varieti
new
pathogen
ill
identifi
includ
l
pneumophila
c
pneumonia
hantaviru
sar
viru
coronaviru
addit
antibiot
resist
variant
common
pathogen
pneumonia
pneumococcu
becom
increasingli
common
refer
drugresist
pneumonia
drsp
patient
cap
pneumococcu
includ
drsp
common
pathogen
studi
suggest
may
respons
mani
patient
establish
etiolog
diagnosi
use
standard
diagnost
methodolog
recent
studi
also
suggest
atyp
pathogen
pneumonia
c
pneumonia
l
pneumocphila
common
patient
cap
often
copathogen
along
bacteri
organ
virus
may
present
patient
special
diagnost
test
usual
involv
acut
convalesc
titer
need
thu
explain
ordinari
low
frequenc
document
organ
hemophilu
influenza
common
organ
patient
smoke
cigarett
chronic
obstruct
lung
diseas
enter
gramneg
common
caus
cap
present
hospit
patient
particularli
advanc
age
comorbid
ill
high
likelihood
aspir
gener
certain
specif
patient
risk
infect
specif
pathogen
differ
frequenc
tabl
summar
common
pathogen
caus
cap
outpati
inpati
classif
base
sever
ill
presenc
clinic
risk
factor
specif
pathogen
refer
modifi
factor
patient
sever
cap
may
slightli
differ
spectrum
organ
less
sever
affect
individu
commonli
infect
pneumococcu
atyp
pathogen
enter
gramneg
includ
p
aeruginosa
staphylococcu
aureu
h
influenza
modifi
factor
increas
risk
infect
drsp
age
year
betalactam
therapi
within
past
month
alcohol
immun
suppress
ill
includ
therapi
corticosteroid
multipl
medic
comorbid
exposur
child
day
care
set
modifi
factor
enter
gramneg
includ
resid
nurs
home
underli
cardiopulmonari
diseas
multipl
medic
comorbid
recent
antibiot
therapi
risk
factor
p
aeruginosa
infect
structur
lung
diseas
bronchiectasi
corticosteroid
therapi
mg
day
prednison
broadspectrum
antibiot
therapi
day
past
month
malnutrit
tabl
show
certain
clinic
condit
associ
specif
pathogen
associ
consid
patient
obtain
histori
mention
pneumonia
common
pathogen
cap
patient
popul
possibl
even
among
without
etiolog
recogn
routin
diagnost
test
one
studi
transthorac
needl
aspir
use
defin
etiolog
cap
patient
identifi
organ
convent
diagnost
test
use
polymeras
chain
reaction
pcr
probe
analysi
sampl
half
patient
needl
provid
diagnosi
method
fail
pneumococcu
identifi
organ
gramposit
lancetshap
diplococcu
differ
serotyp
distinct
antigen
polysaccharid
capsul
infect
caus
one
serotyp
includ
vaccin
infect
common
winter
earli
sever
cap
risk
p
aeruginosa
pathogen
plu
p
aeruginosa
pneumococcu
resist
class
agent
patient
recent
expos
spring
may
relat
find
patient
preced
viral
ill
organ
spread
person
person
commonli
colon
oropharynx
lead
pneumonia
pneumonia
develop
colon
organ
aspir
lung
unabl
contain
aspir
inoculum
infect
common
elderli
asplenia
multipl
myeloma
congest
heart
failur
alcohol
influenza
patient
chronic
lung
diseas
patient
hiv
infect
pneumococc
pneumonia
bacteremia
common
healthi
popul
age
classic
radiograph
pattern
lobar
consolid
bronchopneumonia
also
occur
seri
common
pattern
bacteremia
present
hospit
patient
infect
impact
find
mortal
uncertain
extrapulmonari
complic
includ
mening
empyema
arthriti
endocard
brain
abscess
sinc
antibiot
resist
among
pneumococci
becom
increasingli
common
penicillin
resist
along
resist
common
antibiot
macrolid
trimethoprimsulfamethoxizol
select
cephalosporin
present
organ
fortun
us
larg
number
penicillinresist
organ
intermedi
type
penicillin
minimum
inhibitori
concentr
mic
mg
l
highlevel
type
penicillin
mic
mg
l
difficult
show
clinic
impact
vitro
resist
outcom
mortal
larg
number
patient
expert
believ
organ
penicillin
mic
mg
l
still
uncommon
find
lead
increas
risk
death
earli
studi
topic
impact
resist
mortal
adjust
sever
ill
popul
nearli
frequenc
vitro
resist
recent
studi
shown
resist
affect
outcom
group
patient
pneumococc
bacteremia
half
hivposit
highlevel
resist
predictor
mortal
investig
find
increas
risk
death
infect
resist
organ
find
enhanc
likelihood
suppur
complic
empyema
prolong
length
stay
hospit
conflict
data
may
result
studi
rel
patient
mani
high
level
vitro
resist
one
larg
studi
evalu
patient
pneumococc
bacteremia
cap
found
increas
mortal
patient
penicillin
mic
least
mg
l
greater
cefotaxim
mic
mg
l
howev
increas
mortal
present
patient
die
first
day
therapi
exclud
analysi
fortun
organ
current
level
resist
may
explain
conflict
find
variou
studi
recent
anoth
studi
use
cohort
match
control
method
found
sever
ill
resist
accuraci
therapi
import
predictor
mortal
studi
sever
ill
greater
patient
without
resist
organ
impli
loss
virul
among
organ
becom
resist
find
echo
studi
found
absenc
invas
ill
risk
factor
pneumocc
resist
also
conflict
data
impact
discord
therapi
patient
infect
drsp
one
studi
bacterem
infect
antibiot
associ
poor
outcom
presenc
vitro
resist
cefuroxim
anoth
studi
discord
therapi
gener
associ
increas
risk
mortal
multilobar
ill
underli
chronic
obstruct
pulmonari
diseas
copd
hospit
within
past
month
latter
factor
much
risk
death
discord
therapi
also
studi
discord
therapi
less
like
patient
treat
ceftriaxon
cefotaxim
compar
therapi
macrolideresist
pneumococcu
also
occur
increas
frequenc
organ
may
resist
agent
vitro
howev
import
understand
macrolid
resist
us
low
level
due
efflux
mechan
thu
type
resist
may
clinic
relev
local
concentr
macrolid
respiratori
site
infect
may
adequ
effect
therapi
howev
resist
higher
level
due
inabl
antibiot
bind
ribosom
site
action
form
resist
may
much
higher
level
like
clinic
relev
howev
report
macrolid
failur
cap
especi
consid
widespread
use
agent
report
breakthrough
bacteremia
appear
due
organ
resist
either
efflux
ribosom
mechan
like
higher
level
resist
becom
like
futur
impact
outcom
like
appar
resist
pneumococcu
even
report
quinolon
ordinarili
reliabl
class
antibiot
organ
gener
one
import
risk
factor
resist
repeat
use
agent
patient
fact
pneumococc
resist
betalactam
penicillin
cephalosporin
macrolid
quinolon
like
patient
receiv
agent
recent
past
remain
uncertain
long
antibiot
exposur
still
risk
resist
month
report
betalactam
month
macrolid
month
quinolon
data
mind
new
guidelin
suggest
cap
patient
receiv
antibiot
recent
past
rel
arbitrari
cutoff
defin
time
interv
within
past
month
origin
term
atyp
use
describ
unusu
clinic
featur
infect
certain
organ
recent
studi
suggest
term
accur
describ
uniqu
clinic
pneumonia
syndrom
relat
specif
pathogen
howev
term
retain
refer
group
organ
includ
pneumonia
c
pneumonia
legionella
group
organ
reliabl
erad
betalactam
therapi
penicillin
cephalosporin
must
treat
macrolid
ketolid
telithromycin
one
current
avail
tetracyclin
quinolon
recent
studi
shown
infect
common
patient
age
young
healthi
individu
origin
describ
organ
even
report
among
elderli
nurs
home
addit
occur
either
primari
pathogen
may
part
mix
infect
along
tradit
bacteri
pathogen
mix
infect
present
may
lead
complex
cours
longer
length
stay
singl
pathogen
present
may
particular
synergi
c
pneumonia
pneumococcu
either
sequenti
mix
infect
c
pneumonia
lead
sever
cours
pneumococcu
frequenc
atyp
pathogen
high
cap
patient
seri
mani
patient
mix
infect
identifi
although
high
incid
number
deriv
serolog
test
uncertain
accuraci
import
organ
suggest
studi
inpati
shown
reduc
mortal
length
stay
patient
receiv
empir
therapi
account
organ
compar
regimen
account
organ
fact
sever
studi
patient
pneumococc
bacteremia
even
suggest
mortal
benefit
combin
therapi
provid
coverag
atyp
pathogen
well
pneumococcu
atyp
organ
pneumonia
may
constant
phenomenon
frequenc
infect
may
vari
cours
time
geograph
locat
one
studi
benefit
provid
empir
therapi
direct
atyp
pathogen
variabl
import
calendar
year
other
incid
legionella
infect
among
admit
patient
vari
also
reflect
geograph
season
variabl
infect
rate
well
reflect
extent
diagnost
test
legionella
identifi
necessari
collect
acut
convalesc
serolog
studi
patient
sever
cap
atyp
pathogen
present
almost
patient
respons
organ
may
vari
time
one
seri
legionella
common
atyp
pathogen
lead
sever
cap
hospit
decad
later
replac
mycoplasma
chlamydophila
infect
l
pneumophila
small
weakli
stain
gramneg
bacillu
first
character
epidem
occur
either
sporad
epidem
form
present
although
multipl
serogroup
speci
l
pneumophila
describ
serogroup
caus
case
pneumonia
speci
commonli
caus
human
ill
legionella
micdadei
legionella
waterborn
pathogen
eman
aircondit
equip
drink
water
lake
river
bank
water
faucet
sauna
shower
head
infect
common
summer
earli
fall
gener
caus
inhal
infect
aerosol
gener
contamin
water
sourc
water
system
becom
infect
institut
endem
outbreak
may
occur
case
hospit
particularli
patient
receiv
corticosteroid
therapi
sporad
form
legionella
may
account
case
cap
particular
concern
patient
sever
form
ill
mention
difficult
use
clinic
featur
predict
microbi
etiolog
cap
howev
classic
legionella
syndrom
character
high
fever
chill
headach
myalgia
leukocytosi
diagnosi
also
suggest
presenc
pneumonia
preced
diarrhea
along
earli
onset
mental
confus
hyponatremia
rel
bradycardia
liver
function
abnorm
syndrom
usual
present
symptom
rapidli
progress
patient
may
appear
quit
toxic
diagnosi
alway
consid
patient
admit
icu
cap
pneumonia
caus
cap
yearround
slight
increas
fall
winter
age
group
affect
although
common
less
year
age
also
common
caus
cap
even
older
adult
respiratori
infect
occur
organ
inhal
bind
via
neuramin
acid
receptor
airway
epithelium
inflammatori
respons
neutrophil
lymphocyt
macrophag
follow
accompani
format
immunoglobulin
igm
igg
antibodi
observ
pneumon
may
mediat
host
respons
organ
rather
direct
tissu
injuri
mycoplasma
infect
individu
circul
immun
complex
although
mycoplasma
caus
pneumonia
infect
often
character
extrapulmonari
manifest
half
patient
upper
respiratori
tract
symptom
includ
sore
throat
earach
hemorrhag
bullou
myring
pleural
effus
quit
common
seen
least
patient
pneumonia
although
may
small
extrapulmonari
manifest
includ
neurolog
ill
meningoenceph
mening
transvers
myeliti
cranial
nerv
palsi
common
extrapulmonari
find
igm
autoantibodi
direct
antigen
red
blood
cell
caus
cold
agglutin
erythrocyt
although
patient
may
antibodi
posit
coomb
test
clinic
signific
autoimmun
hemolyt
anemia
uncommon
system
complic
includ
myocard
pericard
hepat
gastroenter
erythema
multiform
arthralgia
pancreat
gener
lymphadenopathi
glomerulonephr
extrapulmonari
manifest
may
follow
respiratori
symptom
long
week
common
gramneg
organ
caus
cap
h
influenza
see
enter
gramneg
gener
common
cap
unless
patient
elderli
chronic
cardiac
pulmonari
diseas
healthcar
associ
pneumonia
alcohol
patient
organ
e
coli
k
pneumonia
found
p
aeruginosa
uncommon
caus
cap
isol
patient
cap
bronchiectasi
sever
form
cap
particularli
elderli
patient
age
controversi
persist
commonli
enter
gramneg
bacteria
caus
cap
howev
one
larg
studi
hospit
cap
patient
care
diagnost
test
identifi
gramneg
enter
half
p
aeruginosa
identifi
risk
factor
gramneg
infect
probabl
aspir
previou
hospit
admiss
within
day
admiss
previou
antibiot
within
day
admiss
presenc
pulmonari
comorbid
risk
factor
p
aeruginosa
pulmonari
comorbid
previou
hospit
infect
gramneg
increas
chanc
die
threefold
mortal
rate
patient
also
need
icu
admiss
mechan
ventil
often
patient
organ
organ
alway
concern
patient
poor
dentit
aspir
oral
content
risk
patient
neurolog
swallow
disord
well
individu
abus
alcohol
opiat
drug
sever
recent
studi
question
whether
organ
realli
common
patient
risk
factor
aspir
one
evalu
resid
longterm
care
facil
sever
aspir
pneumonia
defin
presenc
risk
factor
oropharyng
aspir
requir
icu
admiss
bacteriolog
determin
protect
bronchoalveolar
lavag
bal
within
h
admiss
pathogen
identifi
organ
enter
gramneg
anaerob
aureu
mani
anaerob
recov
aerob
gramneg
presenc
correl
oral
hygien
presenc
gramneg
correl
function
statu
common
patient
total
depend
mani
patient
receiv
inadequ
therapi
anaerob
yet
recov
rais
question
whether
infect
organ
realli
need
treat
find
suggest
anaerob
may
alway
pathogen
may
colon
institution
elderli
includ
aspir
risk
factor
gramneg
coccobacillari
rod
occur
either
typabl
encapsul
form
nontyp
unencapsul
form
encapsul
organ
one
seven
type
type
b
account
invas
infect
encapsul
organ
requir
elabor
host
respons
thu
virul
unencapsul
organ
howev
sever
studi
shown
adult
particularli
copd
infect
unencapsul
bacteria
common
infect
encapsul
organ
organ
may
caus
bacterem
pneumonia
patient
particularli
segment
pneumonia
oppos
bronchopneumonia
encapsul
type
b
organ
common
patient
segment
pneumonia
bronchopneumonia
patient
infect
underli
ill
alcohol
smoke
histori
copd
cap
also
caus
aureu
lead
sever
ill
cavitari
lung
infect
organ
also
seed
lung
hematogen
veget
patient
rightsid
endocard
septic
venou
thrombophleb
central
venou
cathet
jugular
vein
infect
patient
develop
post
influenza
pneumonia
aureu
lead
secondari
bacteri
infect
along
pneumococcu
h
influenza
recent
report
cap
caus
methicillinresist
aureu
mrsa
becom
common
occurr
may
chang
way
diseas
treat
empir
date
patient
mrsa
cap
sever
necrot
pneumonia
gener
follow
influenza
anoth
viral
infect
organ
respons
specif
virul
factor
pantonvalentin
leukocidin
organ
caus
pneumonia
appear
genet
relat
incid
viral
pneumonia
difficult
defin
epidem
time
influenza
consid
lead
primari
viral
pneumonia
secondari
bacteri
pneumonia
one
care
studi
nonimmunecompromis
cap
patient
collect
pair
sera
respiratori
virus
found
viral
pneumonia
half
pure
viral
infect
other
mix
bacteri
pneumonia
patient
congest
heart
failur
risk
pure
viral
pneumonia
pneumococc
infect
influenza
b
parainfluenza
adenoviru
commonli
identifi
viral
caus
cap
influenza
b
still
remain
common
caus
viral
pneumonia
vigil
new
agent
essenti
evidenc
recent
experi
sar
demonstr
potenti
epidem
persontoperson
spread
virul
respiratori
viral
infect
continu
concern
epidem
viral
pneumonia
remain
current
worri
focus
avian
influenza
bioterror
agent
smallpox
patient
intact
immun
system
develop
cap
gener
respiratori
symptom
cough
sputum
product
dyspnea
along
fever
complaint
cough
common
find
present
patient
less
common
elderli
seriou
comorbid
individu
come
nurs
home
elderli
gener
fewer
respiratori
symptom
younger
popul
absenc
clearcut
respiratori
symptom
afebril
statu
predictor
increas
risk
death
may
consequ
nonrespiratori
present
indic
impair
immun
respons
well
factor
lead
delay
present
medic
attent
recognit
correct
diagnosi
pleurit
chest
pain
also
commonli
seen
patient
cap
absenc
identifi
poor
prognost
find
elderli
patient
pneumonia
nonrespiratori
present
symptom
confus
fall
failur
thrive
alter
function
capac
deterior
preexist
medic
ill
congest
heart
failur
gener
overal
symptom
less
promin
age
younger
patient
advanc
age
gener
also
longer
durat
symptom
cough
sputum
product
dyspnea
fatigu
anorexia
myalgia
abdomin
pain
younger
patient
studi
found
associ
type
etiolog
microorgan
clinic
present
cap
except
pleurit
chest
pain
like
common
pneumonia
caus
bacteri
pathogen
pneumonia
nonbacteri
pneumonia
delirium
acut
confus
frequent
elderli
patient
pneumonia
agematch
control
pneumonia
elderli
patient
pneumonia
consid
well
nourish
kwashiorkorlik
malnutrit
predomin
type
nutrit
defect
one
associ
delirium
initi
present
physic
find
pneumonia
includ
tachypnea
crackl
rhonchi
sign
consolid
egophoni
bronchial
breath
sound
dull
percuss
patient
also
examin
sign
pleural
effus
addit
extrapulmonari
find
sought
rule
metastat
infect
arthriti
endocard
mening
add
suspicion
atyp
pathogen
pneumonia
c
pneumonia
one
import
evalu
patient
suspect
pneumonia
measur
respiratori
rate
elderli
elev
respiratori
rate
may
initi
present
sign
pneumonia
preced
clinic
find
much
day
prospect
evalu
longterm
care
set
patient
diagnos
lower
respiratori
tract
infect
respiratori
rate
normal
rang
min
gener
elev
rate
preced
clinic
find
although
find
certainli
specif
appear
sensit
indic
presenc
respiratori
infect
gener
tachypnea
common
find
elderli
patient
pneumonia
present
patient
present
often
elderli
younger
patient
pneumonia
measur
respiratori
rate
diagnost
valu
also
prognost
signific
evalu
patient
cap
find
respiratori
rate
min
one
sever
factor
associ
increas
mortal
past
clinic
radiograph
featur
cap
character
fit
pattern
either
typic
atyp
symptom
pattern
use
predict
specif
etiolog
agent
recent
studi
shown
approach
highli
accur
weak
relationship
clinic
featur
etiolog
pathogen
primarili
host
well
pathogen
factor
play
role
defin
patient
symptom
typic
pneumonia
syndrom
character
sudden
onset
high
fever
shake
chill
pleurit
chest
pain
lobar
consolid
toxic
appear
patient
product
purul
sputum
although
pattern
attribut
pneumococcu
bacteri
pathogen
organ
alway
lead
classic
symptom
especi
elderli
discuss
atyp
pneumonia
syndrom
character
subacut
ill
nonproduct
cough
headach
diarrhea
system
complaint
usual
result
infect
pneumonia
c
pneumonia
legionella
sp
virus
howev
patient
impair
immun
respons
especi
elderli
chronic
ill
may
present
fashion
even
bacteri
pneumonia
clinic
featur
shown
accur
differenti
pneumococcu
pneumonia
pathogen
one
anoth
addit
care
comparison
patient
pneumonia
h
influenza
l
pneumophila
c
pneumonia
shown
signific
differ
clinic
present
limit
clinic
featur
defin
microbi
etiolog
also
appli
evalu
radiograph
pattern
one
import
patient
assess
defin
sever
ill
use
guid
decis
whether
hospit
patient
whether
admit
patient
icu
number
predict
model
develop
predict
sever
ill
guid
admiss
decis
rule
absolut
decis
admit
patient
base
social
well
medic
consider
remain
art
medicin
determin
gener
hospit
use
observ
patient
multipl
risk
factor
poor
outcom
decompens
chronic
ill
need
therapi
easili
administ
home
oxygen
intraven
fluid
cardiac
monitor
risk
factor
poor
outcom
includ
respiratori
rate
min
age
year
systol
blood
pressur
mmhg
diastol
blood
pressur
mmhg
multilobar
pneumonia
confus
blood
urea
nitrogen
mg
dl
pao
mmhg
paco
mmhg
respiratori
metabol
acidosi
sign
system
sepsi
two
beststudi
wide
regard
predict
rule
pneumonia
sever
pneumonia
sever
index
psi
rule
modif
prognost
model
develop
british
thorac
societi
psi
use
number
demograph
histor
find
physic
find
laboratori
data
assign
score
patient
score
use
categor
patient
one
five
class
differ
risk
death
tool
work
well
defin
mortal
risk
variabl
success
predict
need
admiss
cumbersom
use
discrimin
well
among
sever
ill
patient
rule
simpler
use
five
assess
confus
mmol
l
respiratori
min
blood
mmhg
systol
mm
diastol
age
year
five
criteria
score
score
rise
mortal
risk
rise
recent
studi
tool
work
equal
well
identifi
patient
low
risk
die
discrimin
recogn
patient
need
icu
care
score
least
highest
risk
death
major
differ
two
model
psi
weight
advanc
age
chronic
ill
heavili
model
includ
age
one
sever
risk
factor
comorbid
ill
measur
instead
score
base
acut
physiolog
abnorm
none
predict
model
includ
social
factor
score
system
clearli
issu
need
includ
patient
assess
pay
attent
whether
patient
stabl
home
environ
outpati
care
abil
take
oral
medic
absenc
acut
alcohol
drug
intox
stabil
acut
chronic
medic
problem
specif
rule
admit
icu
gener
icu
use
approxim
cap
patient
popul
mortal
rate
least
compar
mortal
rate
admit
patient
mortal
rate
outpati
debat
benefit
icu
care
patient
cap
benefit
seem
certain
patient
admit
earli
cours
sever
ill
make
assess
mortal
risk
import
clinic
assess
criteria
icu
admiss
addit
need
mechan
ventil
septic
shock
presenc
least
two
follow
pao
fio
ratio
multilobar
infiltr
systol
blood
pressur
mmhg
entri
point
treatment
algorithm
cap
presenc
new
radiograph
infiltr
patient
ill
find
first
evalu
even
radiograph
neg
patient
appropri
symptom
focal
physic
find
pneumonia
may
still
present
one
studi
nearli
patient
clinic
sign
symptom
cap
evalu
chest
radiograph
highresolut
comput
tomographi
ct
scan
chest
almost
patient
identifi
ct
scan
pneumonia
neg
chest
radiograph
addit
extens
abnorm
found
ct
scan
mani
patient
present
chest
radiograph
find
studi
confirm
need
repeat
chest
film
h
certain
symptomat
patient
initi
neg
chest
film
reason
initi
neg
chest
film
clear
studi
suggest
febril
dehydr
patient
normal
radiograph
first
admit
although
idea
hydrat
pneumonia
realm
convent
wisdom
anecdot
report
although
varieti
radiograph
pattern
seen
pneumonia
radiograph
find
gener
use
predict
microbi
etiolog
cap
certain
pattern
associ
specif
pathogen
focal
consolid
seen
infect
caus
pneumococcu
k
pneumonia
upper
lobe
consolid
classic
bulg
upper
lobe
fissur
aspir
especi
lower
lobe
depend
segment
aureu
h
influenza
pneumonia
c
pneumonia
interstiti
infiltr
suggest
viral
pneumonia
well
infect
due
pneumonia
c
pneumonia
chlamydia
psittaci
pneumocysti
jerovici
lymphadenopathi
interstiti
pattern
rais
concern
anthrax
francisella
tularensi
c
psittaci
adenopathi
seen
focal
infiltr
tuberculosi
fungal
pneumonia
bacteri
pneumonia
cavit
result
aspir
lung
abscess
infect
aureu
aerob
gramneg
includ
p
aeruginosa
tuberculosi
fungal
infect
nocardia
actinomycosi
pleural
effus
may
appear
initi
chest
radiograph
present
necessari
distinguish
empyema
simpl
parapneumon
effus
sampl
pleural
fluid
pneumococc
pneumonia
infect
commonli
complic
effus
patient
pathogen
caus
effus
includ
h
influenza
pneumonia
legionella
tuberculosi
clinic
evalu
suggest
presenc
pneumonia
diagnosi
confirm
chest
radiograph
although
patient
may
clinic
find
pneumonia
focal
crackl
bronchial
breath
sound
neg
chest
radiograph
need
antibiot
therapi
cap
establish
studi
patient
radiograph
infiltr
popul
elderli
chronic
ill
clinic
diagnosi
difficult
individu
chest
radiograph
essenti
defin
presenc
parenchym
lung
infect
although
radiograph
recommend
outpati
inpati
may
impract
set
outsid
hospit
chest
radiograph
confirm
presenc
pneumonia
use
identifi
complic
ill
grade
sever
diseas
note
find
pleural
effus
multilobar
ill
mention
specif
radiograph
pattern
use
defin
etiolog
pathogen
cap
certain
find
use
suggest
specif
organ
anaerob
cavitari
infiltr
found
tuberculosi
posterior
upper
lobe
infiltr
present
even
extens
test
patient
specif
pathogen
identifi
mani
diagnosi
made
day
week
later
result
cultur
serolog
test
becom
avail
addit
recent
studi
emphas
mortal
benefit
prompt
administr
effect
antibiot
therapi
goal
administ
intraven
antibiot
within
h
admiss
hospit
moder
sever
ill
thu
therapi
never
delay
purpos
diagnost
test
diagnost
workup
streamlin
patient
receiv
empir
therapi
base
predict
like
pathogen
soon
possibl
recommend
test
outpati
limit
chest
radiograph
puls
oximetri
avail
sputum
cultur
consid
patient
suspect
unusu
drugresist
pathogen
admit
patient
diagnost
test
includ
chest
radiograph
assess
oxygen
puls
oximetri
blood
ga
latter
retent
carbon
dioxid
suspect
routin
admiss
blood
work
patient
pleural
effus
tap
fluid
sent
cultur
biochem
analysi
although
blood
cultur
posit
cap
patient
use
defin
specif
diagnosi
defin
presenc
drugresist
pneumococci
one
concern
blood
cultur
limit
patient
reason
likelihood
posit
lowrisk
patient
routin
blood
cultur
possibl
frequenc
fals
posit
may
exceed
true
posit
lead
inaccur
unnecessari
therapi
one
studi
larg
medicar
databas
found
predictor
bacteremia
among
admit
patient
absenc
prior
antibiot
comorbid
liver
diseas
systol
blood
pressur
mmhg
fever
puls
min
blood
urea
nitrogen
mg
dl
serum
sodium
white
blood
cell
count
base
find
blood
cultur
greatest
yield
true
posit
result
patient
least
one
risk
factor
none
also
histori
receiv
antibiot
prior
admiss
sputum
cultur
limit
patient
suspect
infect
drugresist
unusu
pathogen
role
gram
stain
sputum
guid
initi
antibiot
therapi
controversi
test
greatest
valu
guid
interpret
sputum
cultur
use
defin
predomin
organ
present
sampl
role
gram
stain
focus
initi
antibiot
therapi
uncertain
sinc
accuraci
test
predict
cultur
recoveri
organ
pneumococcu
depend
criteria
use
investig
shown
practic
limit
test
fewer
half
patient
even
produc
sputum
sampl
half
valid
diagnost
thu
uncommon
choos
antibiot
direct
diagnost
result
even
gram
stain
find
use
focu
antibiot
therapi
would
allow
empir
coverag
atyp
pathogen
might
present
pneumococcu
part
mix
infect
spite
limit
gram
stain
use
broaden
initi
empir
therapi
enhanc
suspicion
organ
cover
routin
empir
therapi
aureu
suggest
presenc
cluster
gramposit
cocci
especi
time
epidem
influenza
routin
serolog
test
recommend
howev
patient
sever
ill
diagnosi
legionella
made
urinari
antigen
test
test
like
posit
time
admiss
test
specif
serogroup
infect
commerci
avail
test
pneumococc
urinari
antigen
develop
role
clinic
manag
cap
still
defin
bronchoscopi
indic
routin
diagnost
test
restrict
immunecompromis
patient
select
individu
sever
form
cap
initi
therapi
patient
cap
focus
provis
antibiot
support
care
antibiot
given
empir
basi
sinc
virtual
imposs
reli
clinic
laboratori
data
provid
exact
etiolog
pathogen
time
initi
diagnosi
thu
therapi
must
focus
pathogen
like
present
given
type
patient
support
care
includ
oxygen
need
hydrat
possibl
chest
physiotherapi
well
bronchodil
expector
sever
ill
patient
may
necessari
support
blood
pressur
pressor
use
corticosteroid
possibl
rel
adren
insuffici
provid
therapi
direct
sign
sepsi
drotrecogin
alpha
select
patient
may
also
benefit
routin
use
corticosteroid
sever
pneumonia
unclear
reason
studi
shown
surviv
benefit
intervent
initi
empir
therapi
select
categor
patient
basi
place
therapi
outpati
inpati
icu
sever
ill
presenc
absenc
cardiopulmonari
diseas
specif
modifi
factor
make
certain
pathogen
like
use
factor
set
like
pathogen
predict
type
patient
tabl
inform
use
guid
therapi
specif
pathogen
subsequ
identifi
diagnost
test
therapi
focus
choos
empir
therapi
cap
certain
principl
follow
tabl
empir
therapi
outpati
cardiopulmonari
diseas
modifi
factor
new
oral
macrolid
azithromycin
clarithromycin
tetracyclin
although
erythromycin
use
patient
valu
limit
lack
coverag
h
influenza
higher
frequenc
intestin
complic
nausea
vomit
newer
macrolid
therapi
antipneumococc
quinolon
gatifloxacin
gemifloxacin
levofloxacin
moxifloxacin
necessari
outpati
risk
organ
drsp
enter
gramneg
howev
outpati
cardiopulmonari
diseas
andor
modifi
factor
receiv
macrolid
monotherapi
treat
either
select
oral
betalactam
tabl
macrolid
monotherapi
use
oral
antipneumococc
quinolon
gatifloxacin
gemifloxacin
levofloxacin
moxifloxacin
alon
ketolid
telithromycin
also
use
popul
oral
monotherapi
patient
risk
drsp
risk
factor
aspir
enter
gramneg
nonicu
inpati
therapi
intraven
macrolid
azithromycin
alon
provid
patient
underli
cardiopulmonari
diseas
risk
factor
infect
drsp
enter
gramneg
anaerob
although
patient
type
admit
hospit
macrolid
monotherapi
document
effect
popul
major
inpati
cardiopulmonari
diseas
andor
modifi
factor
treat
either
select
intraven
betalactam
tabl
combin
macrolid
receiv
intraven
antipneumococc
quinolon
gatifloxacin
levofloxacin
moxifloxacin
alon
avail
data
appear
either
regimen
therapeut
equival
although
proven
may
use
use
two
type
regimen
interchang
strive
antibiot
heterogen
select
agent
differ
class
patient
receiv
past
month
although
oral
quinolon
may
effect
intraven
quinolon
admit
patient
tabl
principl
antibiot
therapi
administ
initi
antibiot
therapi
within
h
arriv
hospit
treat
patient
pneumococcu
possibl
atyp
pathogen
coinfect
use
either
macrolid
alon
select
patient
cardiopulmonari
diseas
modifi
factor
outpati
cardiopulmonari
diseas
modifi
factor
use
monotherapi
quinolon
ketolid
risk
factor
enter
gramneg
combin
select
betalactam
macrolid
ketolid
tetracyclin
limit
macrolid
monotherapi
outpati
inpati
risk
factor
drsp
enter
gramneg
aspir
limit
ketolid
monotherapi
outpati
risk
factor
drsp
risk
factor
enter
gramneg
provid
initi
therapi
hospit
patient
intraven
agent
oral
use
quinolon
patient
risk
drsp
accept
oral
betalactam
cefpodoxim
cefuroxim
highdos
ampicillin
g
day
amoxicillinclavulan
g
day
inpati
risk
drsp
select
accept
intraven
betalactam
includ
ceftriaxon
cefotaxim
ertapenem
ampicillinsulbactam
limit
antipseudomon
therapi
patient
risk
factor
antipseudomon
agent
includ
betalactam
cefepim
imipenem
meropenem
piperacillintazobactam
quinolon
ciprofloxacin
highdos
levofloxacin
mg
day
aminoglycosid
amikacin
gentamicin
tobramycin
aztreonam
monobactam
also
activ
use
alon
new
antipneumococc
quinolon
order
decreas
antipneumococc
activ
gemifloxacin
oral
moxifloxacin
oral
intraven
gatifloxacin
oral
intraven
levofloxacin
oral
intraven
never
use
monotherapi
patient
sever
cap
pseudomon
risk
factor
use
select
betalactam
plu
macrolid
antipneumococc
quinolon
pseudomon
risk
factor
use
antipseudomon
betalactam
plu
either
ciprofloxacinhighdos
levofloxacin
combin
aminoglycosid
either
macrolid
antipneumococc
quinolon
vancomyin
linezolid
use
rare
sever
cap
either
mening
vancomycin
sever
necrot
pneumonia
influenza
either
agent
moder
sever
ill
admit
patient
receiv
initi
therapi
intraven
sure
medic
absorb
patient
show
good
clinic
respons
oral
therapi
start
select
inpati
mild
moder
diseas
initi
treat
combin
intraven
betalactam
oral
macrolid
switch
exclus
oral
therapi
patient
show
good
clinic
respons
icu
popul
individu
treat
drsp
atyp
pathogen
appropri
risk
factor
coverag
p
aeruginosa
sinc
efficaci
dose
safeti
quinolon
monotherapi
establish
icuadmit
cap
patient
therapi
patient
absenc
pseudomon
risk
factor
select
intraven
betalactam
combin
either
intraven
macrolid
intraven
quinolon
patient
pseudomon
risk
factor
therapi
twodrug
regimen
use
antipseudomon
betalactam
cefepim
imipenem
meropenem
piperacillintazobactam
plu
ciprofloxacin
highdos
levofloxacin
altern
threedrug
regimen
use
antipseudomon
betalactam
plu
aminoglycosid
plu
either
intraven
nonpseudomon
quinolon
macrolid
antipneumococc
quinolon
wide
use
inpati
outpati
monotherapi
singl
drug
given
daili
possibl
cover
pneumococcu
includ
drsp
gramneg
atyp
pathogen
quinolon
penetr
well
respiratori
secret
highli
bioavail
achiev
serum
level
oral
intraven
therapi
therebi
allow
moder
ill
outpati
manag
effect
oral
antibiot
differ
among
avail
agent
intrins
activ
pneumococcu
base
mic
data
agent
rank
least
activ
gemifloxacin
avail
oral
form
moxifloxacin
gatifloxacin
levofloxacin
data
suggest
lower
likelihood
clinic
failur
induct
pneumocc
resist
quinolon
activ
agent
use
place
less
activ
agent
addit
gener
approach
therapi
outlin
sever
therapeut
issu
manag
cap
highlight
tabl
includ
need
time
administr
initi
antibiot
therapi
limit
use
therapi
direct
methicillinresist
aureu
need
routin
atyp
pathogen
coverag
patient
emphasi
use
highli
activ
agent
patient
risk
factor
infect
drsp
reason
last
recommend
patient
risk
infect
drsp
use
highli
activ
agent
like
minim
risk
treatment
failur
may
also
rapidli
reliabl
erad
pneumococc
organ
low
level
resist
less
select
pressur
emerg
organ
high
level
resist
major
outpati
inpati
respond
rapidli
empir
therapi
regimen
suggest
clinic
respons
usual
occur
within
h
clinic
respons
inpati
defin
improv
symptom
cough
sputum
product
dyspnea
along
abil
take
medic
mouth
afebril
statu
least
two
occas
h
apart
patient
met
criteria
clinic
respons
appropri
switch
oral
therapi
regimen
discharg
patient
otherwis
medic
social
stabl
radiograph
improv
lag
behind
clinic
improv
respond
patient
chest
radiograph
necessari
week
start
therapi
patient
fail
respond
therapi
expect
time
interv
necessari
consid
infect
drugresist
unusu
pathogen
tuberculosi
anthrax
c
burnetii
burkholderia
pseudomallei
pasteurella
multocida
endem
fungi
hantaviru
pneumon
complic
lung
abscess
endocard
empyema
noninfecti
process
mimic
pneumonia
bronchiol
obliteran
organ
pneumonia
hypersensit
pneumon
pulmonari
vascul
bronchoalveolar
cell
carcinoma
lymphoma
pulmonari
embolu
evalu
nonrespond
patient
individu
may
includ
ct
scan
chest
pulmonari
angiographi
bronchoscopi
occasion
open
lung
biopsi
prevent
cap
import
group
patient
especi
elderli
risk
higher
frequenc
infect
sever
cours
ill
appropri
patient
vaccin
pneumococc
influenza
vaccin
cigarett
smoke
stop
atrisk
patient
even
patient
recov
cap
immun
hospit
appropri
prevent
futur
episod
infect
evalu
patient
vaccin
need
provis
inform
smoke
cessarion
perform
standard
use
evalu
hospit
care
cap
patient
pneumococc
vaccin
pneumococc
capsular
polysaccharid
vaccin
prevent
pneumonia
otherwis
healthi
popul
initi
demonstr
south
african
gold
miner
american
militari
recruit
benefit
advanc
age
underli
condit
nonepidem
environ
less
clearli
defin
immunocompet
patient
age
effect
document
vaccin
efficaci
rang
patient
diabet
mellitu
coronari
arteri
diseas
congest
heart
failur
chronic
pulmonari
diseas
anatom
asplenia
effect
proven
immunedefici
popul
sickl
cell
diseas
chronic
renal
failur
immunoglobulin
defici
hodgkin
diseas
lymphoma
leukemia
multipl
myeloma
singl
revaccin
indic
person
age
year
initi
receiv
vaccin
year
earlier
less
year
old
first
vaccin
initi
vaccin
given
age
older
repeat
indic
year
patient
anatom
function
asplenia
one
immun
compromis
condit
list
avail
pneumococc
vaccin
wide
underutil
pneumococc
vaccin
carri
pneumococc
serotyp
caus
major
clinic
infect
seen
us
proteinconjug
pneumococc
vaccin
licens
appear
immunogen
older
vaccin
contain
seven
serotyp
recommend
healthi
children
yet
shown
effect
adult
prevent
pneumococc
bacteremia
hospit
pneumonia
hospitalbas
immun
admit
patient
could
highli
effect
sinc
patient
cap
admit
hospit
indic
preced
year
hospit
could
defin
appropri
time
vaccin
current
vaccin
includ
three
strain
two
influenza
strain
one
influenza
b
strain
vaccin
recommend
patient
age
chronic
medic
ill
includ
nurs
home
resid
provid
healthcar
patient
risk
complic
influenza
given
yearli
usual
septemb
mid
novemb
northern
hemispher
vaccin
match
circul
strain
influenza
prevent
ill
healthi
person
age
older
person
chronic
ill
efficaci
less
vaccin
still
attenu
influenza
infect
lead
fewer
lower
respiratori
tract
infect
associ
morbid
mortal
follow
influenza
